# Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery

> **NCT01313377** · PHASE3 · COMPLETED · sponsor: **UNICANCER** · enrollment: 190 (actual)

## Conditions studied

- Extrahepatic Bile Duct Cancer
- Gallbladder Cancer
- Liver Cancer

## Interventions

- **DRUG:** gemcitabine hydrochloride
- **DRUG:** oxaliplatin
- **OTHER:** clinical observation
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT01313377
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 190 (ACTUAL)
- **Last updated:** 2017-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01313377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01313377, "Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT01313377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*